The dilemma of whether to continue TNFα blocker therapy in an ulcerative colitis patient newly diagnosed with a malignant melanoma and melanoma in situ
Louise Zuzarte, Sara Mirhadi, Richard A Carr, Simon Tso
A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf.
Louise Zuzarte, Sara Mirhadi, Richard A Carr, Simon Tso. "The dilemma of whether to continue TNFα blocker therapy in an ulcerative colitis patient newly diagnosed with a malignant melanoma and melanoma in situ." BMJ Case Reports 12.11 (2019) e232536